FDA Investigator: Pal S. Mayasandra
- Pal S. Mayasandra first started conducting FDA inspections in 2009, with the last inspection in 2013. Over that time, Pal S. Mayasandra has conducted 19 inspections at 18 companies across 19 sites.
Get Pal Mayasandra's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Wockhardt Limited - Baddi, Solan, Nalagarh | 2013
Out-of-stock
Pal S. Mayasandra
Human Drug Form 483
FDA 483 Wockhardt Limited - Baddi, Solan, Nalagarh | 2013
Out-of-stock
Pal S. Mayasandra
Human Drug Form 483
FDA 483 SmithKline Beecham Limited, Worthing | 2012
Out-of-stock
Pal S. Mayasandra
Human Drug Form 483
FDA 483 Arrow Pharm Limited, Birzebbugia | 2012
Out-of-stock
Pal S. Mayasandra
Human Drug Form 483
FDA 483 Orgapharm, SAS, Pithiveirs | 2010
Out-of-stock
Pal S. Mayasandra
Human Drug Form 483
FDA 483 Vista Pharmaceuticals, Ltd., Narket Palli | 2009
Out-of-stock
Pal S. Mayasandra
Human Drug Form 483
FDA 483 Cephazone Pharma, LLC, Pomona | 2009
Out-of-stock
Pal S. Mayasandra
Human Drug Form 483
Co-Investigators (9)
- Marie F. Morin, FDA Investigator
- Stephen D. Brown, FDA Investigator
- David J. Gomes, FDA Investigator
- Susan D. Yuscius, FDA Investigator
- Christopher T. Middendorf, FDA Investigator
- Mark R. McClain, FDA Investigator
- John A. Gonzalez, FDA Investigator
- Jennifer M. Gogley, FDA Investigator
- Jamie M. Du, FDA Investigator